Ipilimumab vs Warfarin

## Ipilimumab vs Warfarin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Warfarin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Warfarin**: Inhibits vitamin K epoxide reductase complex.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Warfarin — 20-60 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Warfarin — C19H16O4.

**Molecular Weight**: Ipilimumab — N/A; Warfarin — 308.3280 g/mol.

**Type**: Ipilimumab — Antibody; Warfarin — Small molecule.